Table 2.
Prognostic characteristics for intravascular lymphomatosis.
| Clinical prognostic factor | Time from diagnosis to death | P |
|---|---|---|
| Age, years | ||
| <70 | 18.9 (0.1–165.0) | 0.0073* |
| ≥70 | 12.0 (0.1–84.0) | |
| Gender | ||
| Male | 9.3 (0.1–165.0) | 0.6615 |
| Female | 10.0 (0.1–96.0) | |
| Ethnicity | ||
| Asian | 10.0 (0.1–165.0) | 0.0760 |
| Non-Asian | 9.0 (0.1–96.0) | |
| Primary site of disease | ||
| Non-CNS | 19.0 (0.1–165.0) | |
| CNS | 14.0 (0.1–84.0) | 0.0014* |
| 1960–1980′s | 6.0 (0.9–14.0) | |
| 1990's | 8.0 (0.2–71.0) | 0.4187* |
| 2000's | 18.0 (0.3–84.0) | 0.0462* |
| Non-Skin | 9.3 (0.1–165.0) | |
| Skin | 11.0 (0.1–96.0) | 0.3802 |
| 1960–1980's | 19.9 (2.1–42.0) | |
| 1990's | 17.0 (0.3–63.0) | 0.9185* |
| 2000's | 24.0 (0.1–96.0) | 0.6318* |
| Non-BM & Spleen | 9.0 (0.1–165.0) | |
| BM & Spleen | 11.5 (0.1–148.0) | 0.0830 |
| 1990's | 18.0 (0.1–36.0) | |
| 2000's | 17.0 (0.1–148.0) | 0.7102 |
| Non-Lungs | 10.0 (0.1–165.0) | |
| Lungs | 9.0 (0.1–96.0) | 0.7714 |
| 1990's | 9.0 (0.5–96.0) | |
| 2000's | 29.0 (0.1–48.0) | 0.7904* |
| WBC (×109/L) | ||
| Normal | 10.0 (0.1–92.0) | 0.6101 |
| Abnormal | 9.5 (0.1–165.0) | |
| Hgb | ||
| <10.5 g/dL | 10.0 (0.1–148.0) | 0.9471 |
| ≥10.5 g/dL | 10.0 (0.1–165.0) | |
| LDH | ||
| <700 IU/L | 15.0 (1.0–165.0) | 0.0112 |
| ≥700 IU/L | 9.0 (0.1–148.0) | |
| Imaging | ||
| MRI | 10.0 (0.1–165.0) | 0.2551 |
| CT | 9.2 (0.1–165.0) | 0.5043 |
*
P values represent results of Mantel Cox log rank test; all remaining P values represent results of Mann–Whitney U test.